Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 26,200
-250 (-0.95%)
Aug 3, 2026, 3:30 PM KST
-18.13% (1Y)
| Market Cap | 154.06B -18.1% |
| Revenue (ttm) | 211.44B +3.1% |
| Net Income | 26.98B -18.6% |
| EPS | 4,588.16 -18.6% |
| Shares Out | 5.88M |
| PE Ratio | 5.71 |
| Forward PE | 4.63 |
| Dividend | 900.00 (3.40%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 6,119 |
| Open | 26,450 |
| Previous Close | 26,450 |
| Day's Range | 25,950 - 26,500 |
| 52-Week Range | 24,000 - 32,450 |
| Beta | 0.17 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 29, 2026 |